We analyse different regions within tumor samples from time of diagnosis, relapse and metastasis and combine it with data describing RNA, DNA and protein sequences of single cells to study the impact of intra-tumor heterogeneity upon cancer immunity and progression.
Combining these image-based quantitative results with genomic analysis of the cancer-immune interactions can be complementary to identity biomarkers for prediction of treatment response to empower precision oncology.
To help the Right person to get the Right treatment at the Right time.
